drugset / Trial / NCT01703741

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

NCT01703741

Phase 3 Completed 145 enrolled Ferring Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.

Timeline

Start
2012-12
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 23 mg Topical
Subject Testosterone Small molecule 46 mg Topical
Subject Testosterone Small molecule 69 mg Topical

Indications